Packaging & Product Protection Featured Articles

  1. Risk Management Across The Pharmaceutical Product Lifecycle 1/5/2026

    Managing risk throughout the pharmaceutical lifecycle requires proactive strategies. Explore advanced detection methods and rigorous sampling that ensure product integrity.

  2. Microbial Ingress No Longer An Effective CCI Test Method 1/5/2026

    Microbial ingress testing is no longer a reliable measure of container closure integrity. Learn why its variability and limitations demand a shift to deterministic methods that deliver accurate results.

  3. Beyond Visual Inspection: Understanding Acoustical Transparency As A PAT 12/29/2025

    Airborne ultrasound enables non-destructive seal monitoring, detecting subtle material variations. See how this proactive approach enhances consistency, reduces risk, and ensures packaging integrity.

  4. Determining The Limit Of Detection In CCIT 12/18/2025

    Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.

  5. 5 Common Bowie-Dick Test Failures And How To Prevent Them 11/26/2025

    Bowie-Dick test failures indicate serious sterilization issues. Learn the five most common causes and proven strategies to prevent downtime, compliance risks, and compromised product integrity.

  6. Fostering A Quality Software Culture 11/24/2025

    Transforming the quality culture should include the adoption of software quality engineering (SQE), but what is it, and how can it impact the quality of your products and processes?

  7. Why A Dynamic, Digital Defect Library Is Now A Regulatory Expectation 9/17/2025

    Maintaining a dynamic, digital defect library is essential for modern sterile manufacturing. Learn how this approach helps ensure consistency in batch disposition and supports regulatory compliance.

  8. Test Kit Management: The Hidden Weak Point In Your Visual Inspection Program 9/17/2025

    A proper test kit management program is no longer a “nice-to-have”—it’s a compliance necessity. Without a structured system, you risk inspector drift, failed audits, and errors in batch release.

  9. How Non-Destructive Headspace Analysis Advances CCI Testing 9/13/2025

    Opting to use headspace analysis to assess container closure integrity (CCI) for your drug packaging ensures robust data and CCI assurance to protect your product and maintain regulatory compliance.

  10. Advancing Drug Product Quality Through AVI And Future-Ready Infrastructure 9/5/2025

    Automated visual inspection (AVI) combines robotics, precision imaging, and sophisticated defect-recognition software to provide a scalable solution for expanding pipelines and rises in production volumes.